Highlights
NASDAQ: VYGR       Voyager Therapeut
Last Price Today's Change   Day's Range   Trading Volume
13.922   -0.378 (2.64%)  13.85 - 14.55  103,564

Overview

 
Avg Volume (4 weeks):417,689
4 Weeks Range:12.31 - 15.11
4 Weeks Price Volatility (%):
57.57%
52 Weeks Range:7.76 - 28.79
52 Weeks Price Volatility (%):
29.30%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson's, Huntington's and Alzheimer's disease. The company has developed products such as VY-AADC01 for Advanced Parkinson's Disease, VY-HTT01 for Huntington's Disease. Voyager's sole source of revenue is generated through its collaboration with a company called Genzyme. Genzyme funds the collaboration for the multiple gene therapy programs, including programs for Parkinson's disease, Friedreich's ataxia, and Huntington's disease, as well as other CNS disorders.

  Be the first to like this.
 


 

2508  2913  465  3079 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 CHK 0.754+0.011 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 NIO 2.285-0.135 
 SEMG 15.02-0.04 
 AUPH 16.017+7.627 
 CBS 40.77+1.43 
 BNGO 1.106+0.19 
 NAKD 0.034+0.001 
Partners & Brokers